(2S,4S)-4-[4-(3-甲基-1-苯基-1H-吡唑-5-基)-1-哌嗪基]-2-(3-噻唑烷基羰基)-1-吡咯烷羧酸叔丁酯
中文别名:
(2S,4S)-4-[4-(3-甲基-1-苯基-1H-吡唑-5-基)-1-哌嗪基]-2-(3-噻唑烷;(2S,4S)-4-[4-(3-甲基-1-苯基-1H-吡唑-5-基)-1-哌嗪基]-2-(3-噻唑烷基羰基)-1-吡咯烷羧酸叔丁酯;VILDAGLIPTIN杂质54;(2S,4S)-4-[4-(3-甲基-1-苯基-1H-吡唑-5-基)-1-哌嗪基]-2-(3-噻唑烷基羰基)-1-吡咯烷羧酸叔丁酯(2S,4S)-4-[4-(3-甲基-1-苯基-1H-吡唑-5-基)-1-哌嗪基]-2-(3-噻唑烷基羰基)-1-吡咯烷羧酸叔丁酯;维达列汀杂质54;替格列汀杂质B;(2S,4S)-4-(4-(3-甲基-1-苯基-1H-吡唑-5-基)哌嗪-1-基)-2-(噻唑烷-3-羰基)吡咯烷-1-甲酸叔丁酯
英文名称:
(2S,4S)-4-[4-(3-甲基-1-苯基-1H-吡唑-5-基)-1-哌嗪基]-2-(3-噻唑烷基羰基)-1-吡咯烷羧酸叔丁酯
英文别名:
(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic acid tert-butyl ester;Vildagliptin Impurity 54;1-Pyrrolidinecarboxylic acid, 4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-(3-thiazolidinylcarbonyl)-, 1,1-diMethylethyl ester, (2S,4S)-;(2S,4S)-tert-butyl 4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)-2-(thiazolidine-3-carbonyl)pyrrolidine-1-carboxylate;Teneligliptin impurity B Aas per IP;tert-Butyl (2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]-2-[(1,3-thiazolidin-3-yl);Ter-Butyl (2S,4S)-4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-
yl)piperazin-1-yl)-2-(thiazolidine-3-carbonyl)pyrrolidine-1-
carboxylate